Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Nevro Stock Quote

Nevro (NYSE: NVRO)

$12.29
(-3.2%)
-$0.41
Price as of April 17, 2024, 4:00 p.m. ET

Nevro Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
NVRO -66.85% -81.26% -28.45% -50%
S&P +21.68% +73.88% +11.70% +149%

Nevro Company Info

Nevro Corp. engages in the development of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain. It develops and commercializes the senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company was founded by Konstantinos Alataris in March 2006 and is headquartered in Redwood City, CA.

News & Analysis

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.